Cytochrome c oxidase (COX) catalyzes both electron transfer from cytochrome c to molecular oxygen and the concomitant vectorial proton pumping across the inner mitochondrial membrane. Studying a large family with multiple cases of neonatal ketoacidotic comas and isolated COX deficiency, we have mapped the disease locus to chromosome 17p13.1, in a region encompassing two candidate genes involved in COX assembly-namely, SCO1 and COX10. Mutation screening revealed compound heterozygosity for SCO1 gene mutations in the patients. The mutated allele, inherited from the father, harbored a 2-bp frameshift deletion (DeltaGA; nt 363-364) resulting in both a premature stop codon and a highly unstable mRNA. The maternally inherited mutation (C520T) changed a highly conserved proline into a leucine in the protein (P174L). This proline, adjacent to the CxxxC copper-binding domain of SCO1, is likely to play a crucial role in the tridimentional structure of the domain. Interestingly, the clinical presentation of SCO1-deficient patients markedly differs from that of patients harboring mutations in other COX assembly and/or maturation genes.
The Xq28 duplication involving the gene ( duplication) has been mainly described in male patients with severe developmental delay (DD) associated with spasticity, stereotypic movements and recurrent infections. Nevertheless, only a few series have been published. We aimed to better describe the phenotype of this condition, with a focus on morphological and neurological features. Through a national collaborative study, we report a large French series of 59 affected males with interstitial duplication. Most of the patients (93%) shared similar facial features, which evolved with age (midface hypoplasia, narrow and prominent nasal bridge, thick lower lip, large prominent ears), thick hair, livedo of the limbs, tapered fingers, small feet and vasomotor troubles. Early hypotonia and global DD were constant, with 21% of patients unable to walk. In patients able to stand, lower limbs weakness and spasticity led to a singular standing habitus: flexion of the knees, broad-based stance with pseudo-ataxic gait. Scoliosis was frequent (53%), such as divergent strabismus (76%) and hypermetropia (54%), stereotypic movements (89%), without obvious social withdrawal and decreased pain sensitivity (78%). Most of the patients did not develop expressive language, 35% saying few words. Epilepsy was frequent (59%), with a mean onset around 7.4 years of age, and often (62%) drug-resistant. Other medical issues were frequent: constipation (78%), and recurrent infections (89%), mainly lung. We delineate the clinical phenotype of duplication syndrome in a large series of 59 males. Pulmonary hypertension appeared as a cause of early death in these patients, advocating its screening early in life.
Myotonic dystrophy type 1 (DM1) is a dominant multisystemic disorder associated with high variability of symptoms and anticipation. DM1 is caused by an unstable CTG repeat expansion that usually increases in successive generations and tissues. DM1 family pedigrees have shown that ∼90% and 10% of transmissions result in expansions and contractions of the CTG repeat, respectively. To date, the mechanisms of CTG repeat contraction remain poorly documented in DM1. In this report, we identified two new DM1 families with apparent contractions and no worsening of DM1 symptoms in two and three successive maternal transmissions. A new and unique CAG interruption was found in 5' of the CTG expansion in one family, whereas multiple 5' CCG interruptions were detected in the second family. We showed that these interruptions are associated with maternal intergenerational contractions and low somatic mosaicism in blood. By specific triplet-prime PCR, we observed that CTG repeat changes (contractions/expansions) occur preferentially in 3' of the interruptions for both families.
Pathogenic GFM1 variants have been linked to neurological phenotypes with or without liver involvement, but only a few cases have been reported in the literature.Here, we report clinical, biochemical, and neuroimaging findings from nine unrelated children carrying GFM1 variants, 10 of which were not previously reported. All patients presented with neurological involvement-mainly axial hypotonia and dystonia during the neonatal period-with five diagnosed with West syndrome; two children had liver involvement with cytolysis episodes or hepatic failure. While two patients died in infancy, six exhibited a stable clinical course. Brain magnetic resonance imaging showed the involvement of basal ganglia, brainstem, and periventricular white matter. Mutant EFG1 and OXPHOS proteins were decreased in patientʼs fibroblasts consistent with impaired mitochondrial translation. Thus, we expand the genetic spectrum of GFM1linked disease and provide detailed clinical profiles of the patients that will improve the diagnostic success for other patients carrying GFM1 mutations. K E Y W O R D S EFG1, GFM1, mitochondrial diseases, mitochondrial translation, OXPHOS *Metodi D. Metodiev and Benedetta Ruzzenente contributed equally to this study.study did not include brain biopsies, the neurological phenotype that has now emerged as the predominant clinical presentation of GFM1 mutations remains to be explained. Future studies will include more comprehensive biochemical and molecular analyses of patient biopsies as well as animal models expressing GFM1 disease-causing variants to understand their tissue-specific clinical presentations.
ACKNOWLEDGMENTSWe would like to thank the families for their participation in this study. This work was supported in part by grants from the French association against myopathies (AFM-Telethon) to M.D.M. (nrs. 19876 and 22529) and to B.R. (nr. 22251); and grant GENOMITANR-15-RAR3-0012-07 to A.R.
CONFLICT OF INTERESTSThe authors declare that there are no conflict of interests.
ORCID
Manuel Schiffhttp://orcid.org/0000-0001-8272-232XMetodi D. Metodiev
From the description of 2 unrelated patients with succinyl-CoA transferase (3-
OAT) deficiency and 1 patient with acetoacetyl-CoA thiolase (AAT) deficiency, we have
attempted to draw the clinical and metabolic consequences of such defects. The association
of recurrent attacks of severe ketoacidosis with blood glucose levels generally high or normal,
low lactacidemia and low ammonemia is the most common presentation of these disorders.
In 3-OAT deficiency, a potentially fatal disorder, there is a permanent ketosis with the only
excretion of 3-hydroxybutyrate, acetoacetate and 3-hydroxyisovalerate. AAT patients
usually excrete, in addition to the usual ketone bodies, 2-methyl-3-hydroxybutyrate and
tiglylglycine; 2-methyl-acetoacetate may also be present. Both conditions can be identified by
enzymatic analysis in cultured fibroblast. These disorders can mimic diabetic ketoacidosis or
salicylism and can easily be missed. The knowledge of these ketolytic defects must severely
question the complacent diagnosis of ‘fasting ketoacidosis’ or ‘idiopathic ketotic hypoglycemia’,
mainly when severe metabolic acidosis is present.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.